Cargando…
“I just wanted to speak to someone- and there was no one…”: using Burden of Treatment Theory to understand the impact of a novel ATMP on early recipients
BACKGROUND: Advanced therapy medicinal products such as Chimeric antigen receptor T-cell therapy offer ground-breaking opportunities for the treatment of various cancers, inherited diseases, and chronic conditions. With development of these novel therapies continuing to increase it’s important to le...
Autores principales: | Litchfield, Ian, Calvert, Melanie J., Kinsella, Francesca, Sungum, Nisha, Aiyegbusi, Olalekan L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111696/ https://www.ncbi.nlm.nih.gov/pubmed/37069697 http://dx.doi.org/10.1186/s13023-023-02680-y |
Ejemplares similares
-
Patient and public perspectives on cell and gene therapies: a systematic review
por: Aiyegbusi, Olalekan Lee, et al.
Publicado: (2020) -
“You just want someone to help”: Outcomes that matter to parents when their child is treated for chronic pain
por: Joslin, Rhiannon, et al.
Publicado: (2023) -
General practitioners’ views on use of patient reported outcome measures in primary care: a cross-sectional survey and qualitative study
por: Turner, Grace M., et al.
Publicado: (2020) -
Surgery Versus ATMPs: An Example From Ophthalmology
por: Magrelli, Federica M., et al.
Publicado: (2020) -
Development and usability testing of an electronic patient-reported outcome (ePRO) solution for patients with inflammatory diseases in an Advanced Therapy Medicinal Product (ATMP) basket trial
por: McMullan, Christel, et al.
Publicado: (2023)